Literature DB >> 24803875

Gastrointestinal endoscopy in patients taking novel oral anticoagulants.

James Aisenberg1.   

Abstract

Entities:  

Year:  2014        PMID： 24803875      PMCID： PMC4011376     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Novel oral anticoagulants in gastroenterology practice.

Authors:  Jay Desai; Christopher B Granger; Jeffrey I Weitz; James Aisenberg
Journal:  Gastrointest Endosc       Date:  2013-05-29       Impact factor: 9.427

Review 2.  Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.

Authors:  Jay Desai; Jennifer M Kolb; Jeffrey I Weitz; James Aisenberg
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

3.  Management of antithrombotic agents for endoscopic procedures.

Authors:  Michelle A Anderson; Tamir Ben-Menachem; S Ian Gan; Vasundhara Appalaneni; Subhas Banerjee; Brooks D Cash; Laurel Fisher; M Edwyn Harrison; Robert D Fanelli; Norio Fukami; Steven O Ikenberry; Rajeev Jain; Khalid Khan; Mary Lee Krinsky; David R Lichtenstein; John T Maple; Bo Shen; Laura Strohmeyer; Todd Baron; Jason A Dominitz
Journal:  Gastrointest Endosc       Date:  2009-11-03       Impact factor: 9.427

4.  New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  I Lisanne Holster; Vera E Valkhoff; Ernst J Kuipers; Eric T T L Tjwa
Journal:  Gastroenterology       Date:  2013-03-05       Impact factor: 22.682

Review 5.  Novel anticoagulants: bleeding risk and management strategies.

Authors:  Neena S Abraham; Diana L Castillo
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

6.  Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.

Authors:  Peter Bytzer; Stuart J Connolly; Sean Yang; Michael Ezekowitz; Stephan Formella; Paul A Reilly; James Aisenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-24       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.